ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 


  1. A reflection of the lower rate of infectivity among comorbid conditions in multidrug-resistant tuberculosis
    Smitha Thungathurthi, Prabhakar Orsu
    J App Pharm Sci. 2022; 12(5): 171-177
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120515

  2. Safety profile of remifentanil: A post-marketing study in Indonesia
    Jarir At Thobari, Jonathan Hasian Haposan, Lukman Ade Chandra, Nastia Hidayati, Rianiasa Karunia Dewi, Rita Wahyu Purnamasari, Dyah Juliana Pudjiati
    J App Pharm Sci. 2022; 12(5): 165-170
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120514

  3. Antitubercular activities of Crinum asiaticum bulb extract using aeroso-linduced Mycobacterium smegmatis in mice model
    Michael Ofori, Cynthia Amaning Danquah, Paul Poku Sampene Ossei, Gilbrene Rahamani, Isaac Newton Nugbemado, Peace Doe, Theophilus Kwesi Ninkyi
    J App Pharm Sci. 2022; 12(5): 156-164
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120513

  4. Dichloromethane stem bark extract of Goniothalamus lanceolatus Miq. modulates inflammatory cytokines and ameliorates tissue damage in Plasmodium berghei-infected mice
    Rozaini Mohd Zohdi, Fatin Amelina Kaharudin, Shahida Muhamad Mukhtar, Hasidah Mohd Sidek, Nor Hadiani Ismail
    J App Pharm Sci. 2022; 12(5): 149-155
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120512

  5. Impact of COVID-19 pandemic on outpatient depression treatment and NHIF expenditure
    Zornitsa Mitkova, Maria Dimitrova, Javor Mitkov, Guenka Petrova
    J App Pharm Sci. 2022; 12(5): 142-148
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120511

  6. Quillaja saponaria bark saponin attenuates methotrexate induced hepatic oxidative stress, inflammation and associated liver injury in rats
    Mustafa Ahmed Abdel-Reheim, Ahmed Amine Ashour, Mohamed Abdelrazik Khattab, Ahmed Gaafar A. Gaafar
    J App Pharm Sci. 2022; 12(5): 129-141
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120510

  7. In silico screening of hispolon and its analogs: Pharmacokinetics and molecular docking studies with cyclooxygenase-2 enzyme
    Mohadese Mohammadi, Mohammad Firoz Khan, Ridwan Bin Rashid, Sina Mirzaie Nokhostin, Mohammad A. Rashid
    J App Pharm Sci. 2022; 12(5): 120-128
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120509

  8. In silico prediction of interactions and Molecular Dynamics Simulation Analysis of Main Protease of SARS – CoV2 with the FDA approved Non-Protein Antiviral Drugs
    Subramaniam Sivakumar , Sugumar Mohanasundaram, Narasimhan Rangarajan, Venkatesan Sampath, Maderi Velayutham Dass Prakash
    J App Pharm Sci. 2022; 12(5): 104-119
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120508

  9. Promising chitosan - alginate combination for rifampicin dry powder inhaler to target active and latent tuberculosis
    Kurnia Sari Setio Putri, Laily Syahri Ramadhani, Theodora Rachel, Gatot Suhariyono, Silvia Surini
    J App Pharm Sci. 2022; 12(5): 98-103
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120507

  10. Assessing the management of patients with Type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: a pilot study
    Farhana Akter, Mainul Haque, Sanira Akter, Gias Uddin, Naim Chy, Francis Kalemeera, Amanj Kurdi, Kona Chowdhury, Brian Godman
    J App Pharm Sci. 2022; 12(5): 88-97
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120506

  11. Assessment of pH-shift drug interactions of palbociclib by in vitro micro-dissolution in bio relevant media: An analytical QbD-driven RP-HPLC method optimization
    Prajakta Harish Patil, Mrunal Desai, Rajat Radhakrishna Rao, Srinivas Mutalik, Gurupur Gautham Shenoy, Mahadev Rao, Puralae Channabasavaiah Jagadish
    J App Pharm Sci. 2022; 12(5): 78-87
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120505

  12. N-Heterocycle Derivatives: An Update on the Biological Activity in Correlation with Computational Predictions
    Sahar Alghamdi, Rasha suliman, Rawan Alshehri, Razan Almahmoud, Renad Alhujirey
    J App Pharm Sci. 2022; 12(5): 59-77
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120504

  13. QSAR Study of Some Natural and Synthetic Platelet Aggregation Inhibitors and their Pharmacological Profile
    Valery M. Dembitsky, Tatyana A. Gloriozova, Vladimir V. Poroikov, Maju M. Koola
    J App Pharm Sci. 2022; 12(5): 39-58
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120503

  14. Phage therapy: An old concept with new perspectives
    Izabela Durbas, Grzegorz Machnik
    J App Pharm Sci. 2022; 12(5): 27-38
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120502

  15. Advances in vaccine delivery strategies to promote effective immunization
    Bazigha K. Abdul Rasool, Faizah Nazeer Hussain, Insiyah Mustafa Bahrainwala, Nahla Akbar, Salma Umar, Shana Parveen Kalady, Zunaira Shamsheer
    J App Pharm Sci. 2022; 12(5): 1-26
    » Abstract » Full-text PDF » doi: 10.7324/JAPS.2022.120501


Pages: 1...157158159160161162163...235



Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.